Smiling child

Medicare Drug Rule Criticized as Unclear

By Julie Appleby, USA TODAY

More than 1 million people in the Medicare drug program next year will pay almost the full price for certain brand-name drugs when they choose them over generics — a move that advocates for patients say is not clearly spelled out by the government nor insurers.

Click here to read the USA Today article.

DRW Disability Benefit Specialist Program Attorney Eva Shiffrin is quoted in the article.